AI
AGN

Axiom Investors’s Allergan plc AGN Stock Holding History

Axiom Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-154,600
Closed -$31.7M – 163
2017
Q3 		$31.7M Sell
154,600
-21,870
-12% -$5.09M 0.71% 45
2017
Q2 		$42.9M Buy
176,470
+51,358
+41% +$12.1M 1.03% 31
2017
Q1 		$29.9M Buy
+125,112
New +$29.1M 0.77% 52

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Axiom Investors's AGN Position: Q4 2017 in Review

Axiom Investors sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 154,600 shares — an estimated $31.7M sold.

Axiom Investors first reported a position in AGN in Q1 2017 and held it in 3 quarters. The position peaked at $42.9M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Axiom Investors reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Axiom Investors sold 154,600 Allergan plc shares in Q4 2017, an estimated $31.7M.
  • Axiom Investors first reported a position in Allergan plc in Q1 2017 and held it in 3 quarters.
  • Axiom Investors's Allergan plc position peaked at $42.9M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Axiom Investors's 13F filing for Q4 2017, filed 14 Feb 2018.